I
iTeos Therapeutics D
D
ITOS
8.48000
USD
0.30
(3.67%)
Market Open
Volume
9,351
EPS
-4
Div Yield
-
P/E
-3
Market Cap
310,538,303
Novo Nordisk Surges in Profit and Sales
6 months ago
Stocks news More
Title: iTeos Therapeutics
Sector: Healthcare
Industry: Biotechnology
ITeos Therapeutics Inc is a biopharmaceutical company. It designs novel product candidates with optimized pharmacologic properties to improve clinical outcomes by restoring the immune response against cancer. The company's product candidates include EOS-850 which is an Adenosine A2A receptor-specific antagonist, EOS-448 which is an ADCC-enabled, anti-TIGIT immune checkpoint blocking antibody among other drug candidates.